an.adeyemi

TL2 · Nantes

Contributes reviews on supplier material. Based in Nantes.

Joined 27 August 2025 · last posted 10h

88 posts, newest first. Showing up to 150.

Seven-day rolling means and why weekly readings mislead Replied, post #126 · Outcomes › Progress reports · 27 Jul 2026 · 3 likes Post #124 describes the usual case. This is about the unusual one. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like…
Revisiting: What pooling buys you and what it destroys Replied, post #103 · Evidence › Meta-analyses · 23 Jul 2026 · 18 likes Answering the question post #99 raises rather than the one it answers. Individual participant data pooling is a much stronger design than aggregate pooling and is rare…
Does a peptide degrade silently, with no visual change? Replied, post #75 · Practice › Storage & stability · 20 Jul 2026 · 9 likes The arithmetic in post #73 is right; the assumption feeding it is the part to check. Visible particulate is a strong signal in the other direction: it is a reason to…
I joined for one answer and stayed for a year — what changed my mind Replied, post #91 · Start Here › Welcome · 18 Jul 2026 · 22 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Seven-day rolling means and why weekly readings mislead Replied, post #25 · Outcomes › Progress reports · 13 Jul 2026 · 3 likes Where I part company with post #21, and it is a narrow parting. Genuine question rather than a rhetorical one: has anyone here actually observed seven-day rolling, as…
CJC-1295 with and without DAC: what the modification does Replied, post #110 · Compounds › Secretagogues & GH axis · 13 Jul 2026 · 0 likes This follows post #107 rather than contradicting it. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is…
Coming back to: Telehealth prescribing models in the US Replied, post #9 · Regional › North America · 9 Jul 2026 · 13 likes Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else.
Why this subcategory is stricter about sourcing than most Replied, post #53 · Compounds › Secretagogues & GH axis · 7 Jul 2026 · 0 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
What to include when your question involves a chromatogram — one year on Replied, post #57 · Start Here › How to Ask · 30 Jun 2026 · 1 like Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which.…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #59 · Analytics › Home & field testing · 27 Jun 2026 · 12 likes Answering the question post #55 raises rather than the one it answers. Reading a colorimetric result at the wrong time is the commonest procedural error. Development is…
An 18-month record including the parts that went badly Replied, post #29 · Outcomes › Progress reports · 31 May 2026 · 19 likes That matches what I have seen, for whatever a single anecdote is worth.
What to include when your question involves a laboratory result Replied, post #6 · Start Here › How to Ask · 26 May 2026 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Cold solution and stinging: the simplest fix Replied, post #28 · Practice › Administration · 24 May 2026 · 4 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #30 · Practice › Dosing & titration · 19 May 2026 · 1 like Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Injection volume, overload, and peak distortion Replied, post #8 · Analytics › HPLC & UHPLC · 15 May 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
Official shortage notices and what they authorise Replied, post #43 · Access › Shortages · 10 May 2026 · 0 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. It cost nothing to check and would have cost…
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #2 · Analytics › HPLC & UHPLC · 2 May 2026 · 11 likes Taking the opening post at face value and following it one step further. System suitability is not paperwork. If the replicate injections failed, the run did not happen…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #10 · Analytics › Home & field testing · 19 Apr 2026 · 0 likes Agreed on home kit substitute, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
Spike-and-recover accuracy for a peptide assay Replied, post #103 · Analytics › Method validation · 10 Apr 2026 · 15 likes Worth separating two things that post #101 runs together. The question underneath spike-and-recover accuracy is usually "how would I tell?" rather than "what is true?",…
Transporting a vial for a weekend away — a second dataset Replied, post #15 · Practice › Storage & stability · 27 Mar 2026 · 0 likes Narrowing post #14, because the general version has more than one answer. The thing about Transporting a vial that took me longest to accept is that a plausible…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #24 · Sourcing › Logistics · 23 Mar 2026 · 28 likes Picking up post #21: that is the part I would want checked first. The useful distinction on Regional warehouse stock versus direct is between what was measured and what…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #41 · Practice › Administration · 22 Mar 2026 · 0 likes Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is still worth expelling because the bubble occupies volume you…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #41 · Lounge › Introductions · 12 Mar 2026 · 31 likes Welcome. The short version of the culture: be specific, date everything, and say when you are guessing. That is genuinely the whole of it.
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #38 · Compounds › Semaglutide · 7 Mar 2026 · 27 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
Gastro-oesophageal reflux: improving or worsening? Replied, post #24 · Clinical › Comorbidities · 5 Mar 2026 · 11 likes Small correction to my own earlier position on gastro-oesophageal reflux. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #102 · Practice › Dosing & titration · 20 Feb 2026 · 24 likes Worth separating two things that post #98 runs together. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a…
Mass error in ppm: the arithmetic and the caveat Replied, post #81 · Analytics › Mass spectrometry · 14 Feb 2026 · 1 like I had written a reply contradicting post #79 and deleted it. Here is what survived. Response in electrospray is not proportional to abundance across different species.…
Mass error in ppm: the arithmetic and the caveat Replied, post #64 · Analytics › Mass spectrometry · 14 Feb 2026 · 7 likes Following this. I have the same question and no better information than the first post.
Adolescents: a distinct evidence base — one year on Replied, post #60 · Clinical › Special populations · 2 Feb 2026 · 27 likes Adding a data point of agreement rather than a data point.
Trifluoroacetate content and its consequences Replied, post #51 · Analytics › Impurities & related substances · 30 Jan 2026 · 25 likes An update on my earlier trifluoroacetate content post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #6 · Compounds › Secretagogues & GH axis · 2 Jan 2026 · 3 likes That is consistent with mine, for whatever one more account is worth.
Prescription requirements and telehealth models Replied, post #97 · Sourcing › Regulatory · 28 Dec 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Reading SURMOUNT-1 without the press release Replied, post #45 · Compounds › Tirzepatide · 26 Oct 2025 · 15 likes I would call the community position on reading SURMOUNT-1 without the press likely rather than established, and I would be comfortable defending that hedge.
Sleep tracking data and its considerable limitations Replied, post #49 · Wellbeing › Sleep · 21 Oct 2025 · 27 likes On post #45 — agreed on the reasoning, with one qualification. The published data on sleep outcomes in this class is thinner than the volume of discussion, which is…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #26 · Start Here › Welcome · 14 Oct 2025 · 0 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
Can a home kit substitute for a laboratory report? A careful no Replied, post #28 · Analytics › Home & field testing · 11 Oct 2025 · 23 likes I disagree with the framing of home kit substitute above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #128 · Data & Tools › Calculators · 25 Sep 2025 · 10 likes Answering the question post #127 raises rather than the one it answers. The arithmetic on titration planner refuses is the easy part and it is where the errors are,…
Follow-up: Why appetite effects are mostly central Replied, post #49 · Pharmacology › Receptor biology · 24 Sep 2025 · 7 likes Post #46 is right about the mechanism and I think understates the practical bit. Long-term receptor changes: very little is known about what happens to receptor…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #12 · Compounds › Semaglutide · 18 Sep 2025 · 2 likes Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well characterised, and what a particular vial contains, which…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #69 · Evidence › Study critique · 14 Sep 2025 · 16 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #93 · Clinical › Comorbidities · 15 Aug 2025 · 6 likes I think the Cardiovascular risk question is answerable and has not been answered, which is a more optimistic position than most of this thread.
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #11 · Evidence › Preprints · 13 Aug 2025 · 21 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
Documentation that appears only after payment Replied, post #4 · Sourcing › Red flags · 12 Aug 2025 · 18 likes Documentation is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Counter-ion content and its effect on measured mass Replied, post #108 · Analytics › Mass spectrometry · 31 Jul 2025 · 1 like An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error. Filing…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #82 · Compounds › Repair & healing peptides · 27 Jul 2025 · 1 like Route arguments — local versus systemic — are made confidently in this subcategory on very little published basis. The honest position is that the comparison has not…
[2026 update] Splitting an overlong document into two Replied, post #18 · Documentation › Wiki requests · 21 Jul 2025 · 0 likes Everything in post #14 holds. The case it does not cover is the one I have. A calculator request and a document request are different things, and a calculator without a…
When to stop reading forums, including this one Replied, post #5 · Wellbeing › Mental health · 10 Jul 2025 · 18 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #159 · Practice › Reconstitution · 9 Jul 2025 · 0 likes Understood. Thank you for being specific about the limits of it.
Revisiting: What to include when your question involves arithmetic Replied, post #7 · Start Here › How to Ask · 26 Jun 2025 · 8 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #62 · Devices › Pens & autoinjectors · 10 Jun 2025 · 4 likes This follows post #59 rather than contradicting it. Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more than…
Why the timeline is on the right and not the left Replied, post #27 · Meta › Site feedback · 10 Jun 2025 · 14 likes Offering a way to settle timeline rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
[2026 update] An appeal that failed, and what I would do differently Replied, post #20 · Access › Insurance & coverage · 7 Jun 2025 · 8 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #40 · Evidence › Trials · 29 May 2025 · 1 like Answering the question post #36 raises rather than the one it answers. A treatment-policy estimand asks what happens to people assigned to a strategy, including those…
When a preprint is the best available evidence and we say so — a second dataset Replied, post #23 · Evidence › Preprints · 22 May 2025 · 16 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #18 · Clinical › Bloodwork · 11 May 2025 · 0 likes Source for the Building a sensible monitoring schedule figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version…
Follow-up: Documentation that appears only after payment Replied, post #48 · Sourcing › Red flags · 5 May 2025 · 23 likes A certificate that reports a specification in the result column is a documentation defect, and it is a defect people should be able to recognise without it being called…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #94 · Compounds › Semaglutide · 27 Apr 2025 · 20 likes Appetite effects and gastrointestinal effects are frequently reported together and are not the same mechanism reported twice. Slowed gastric emptying contributes to…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #129 · Sourcing › Regulatory · 15 Apr 2025 · 17 likes The practical version of Research-use-only labelling is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
A well-designed study with a badly written abstract Replied, post #11 · Evidence › Study critique · 6 Apr 2025 · 5 likes Where the well-designed study reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Why cagrilintide alone is discussed so much less than in combination Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2025 · 6 likes Everything in post #30 holds. The case it does not cover is the one I have. A note on scope: what I am saying about cagrilintide alone applies to the case in the first…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #53 · Compounds › Secretagogues & GH axis · 24 Mar 2025 · 20 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #60 · Evidence › Journal club · 21 Mar 2025 · 4 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Certificates issued by the seller versus by a laboratory Replied, post #10 · Analytics › COA interpretation · 18 Mar 2025 · 21 likes Answering the question post #7 raises rather than the one it answers. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #118 · Data & Tools › Calculators · 7 Mar 2025 · 24 likes Agreed on all of that, and I have nothing to add to it.
Protein density versus volume when you cannot eat much Replied, post #94 · Nutrition & Training › Protein & intake · 8 Feb 2025 · 0 likes The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more protein" ignores the actual constraint. Reading it again, the…
Protein density versus volume when you cannot eat much Replied, post #71 · Nutrition & Training › Protein & intake · 5 Feb 2025 · 0 likes Post #70 describes the usual case. This is about the unusual one. Where somebody reports losing strength, intake and training stimulus are the first two things to look…
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #32 · Documentation › Doc review · 4 Feb 2025 · 10 likes A document that repeats a paragraph already maintained elsewhere should link instead, unless the reader would be mid-task and unable to follow a link. It took me longer…
Second pass at: Regression to the mean in progress reports Replied, post #43 · Research Methods › Statistics · 2 Feb 2025 · 0 likes Worth stating the null on Regression before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #23 · Evidence › Meta-analyses · 24 Jan 2025 · 1 like Where I part company with post #21, and it is a narrow parting. Reframing Reading a meta-analysis slightly, because I think the disagreement is about the question…
Recovery when intake is low: what to cut first Replied, post #72 · Nutrition & Training › Resistance training · 14 Jan 2025 · 19 likes Answering the question post #70 raises rather than the one it answers. Deload weeks matter more during a deficit than at maintenance because recovery is the limiting…
Follow-up: Individual participant data versus aggregate data Replied, post #70 · Evidence › Meta-analyses · 10 Jan 2025 · 15 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #149 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Body image changing more slowly than the body Replied, post #72 · Wellbeing › Mental health · 19 Dec 2024 · 5 likes Answering the question post #68 raises rather than the one it answers. Two questions I would want answered before drawing anything from the body image data above: how…
Persistent vomiting and the threshold for seeking help — one year on Replied, post #9 · Safety › Adverse events · 18 Dec 2024 · 0 likes Useful. I have added it to my own notes with the date on it.
Promotion criteria, and the one that stops most nominations Replied, post #143 · Documentation › Doc review · 17 Dec 2024 · 11 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #144 · Analytics › COA interpretation · 8 Dec 2024 · 29 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes. For what it is worth, the…
EMA product information as a primary source — does this still hold? Replied, post #109 · Regional › European Union · 18 Nov 2024 · 2 likes I think the EMA product information question is answerable and has not been answered, which is a more optimistic position than most of this thread.
EMA product information as a primary source — does this still hold? Replied, post #97 · Regional › European Union · 17 Nov 2024 · 29 likes The public assessment report published at authorisation is one of the best free technical documents available on any of these compounds and it is rarely cited here.
EMA product information as a primary source — does this still hold? Replied, post #72 · Regional › European Union · 17 Nov 2024 · 2 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
Why "any advice?" is the least effective ending for a post Replied, post #21 · Start Here › How to Ask · 9 Nov 2024 · 0 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
Time to steady state after a dose increase Replied, post #104 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 2 likes Post #103 is the version of this I will quote in future. One addition. Body weight affects volume of distribution and therefore exposure at a fixed dose. Whether that…
Transporting a vial for a weekend away Replied, post #17 · Practice › Storage & stability · 30 Oct 2024 · 3 likes Transporting a vial: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #27 · Pharmacology › Formulation chemistry · 29 Oct 2024 · 21 likes pH is the single most influential formulation variable for peptide stability. Deamidation and hydrolysis rates are strongly pH-dependent and the optimum is usually…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #5 · Clinical › Prescriber conversations · 24 Oct 2024 · 2 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #59 · Clinical › Comorbidities · 19 Oct 2024 · 6 likes This is the first time the answer has come with its own limits attached. Appreciated.
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #76 · Analytics › COA interpretation · 6 Oct 2024 · 18 likes On field-by-field walk through a certificate, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #20 · Clinical › Comorbidities · 5 Oct 2024 · 4 likes That reframing is the whole thing. The facts I already had.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #8 · Sourcing › Independent verification · 20 Aug 2024 · 0 likes Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.